Based on some studies, which demonstrated that decreased omentin levels are associated with increased obesity, insulin resistance, and comorbidities [12, 16–18], we hypothesize that patients with OSA have lower omentin levels. Here, ITLN1 is linked to obesity due to melanocortin 4 receptor deficiency.